Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.
2.

A human Fab-based immunoconjugate specific for the LMP1 extracellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo.

Chen R, Zhang D, Mao Y, Zhu J, Ming H, Wen J, Ma J, Cao Q, Lin H, Tang Q, Liang J, Feng Z.

Mol Cancer Ther. 2012 Mar;11(3):594-603. doi: 10.1158/1535-7163.MCT-11-0725. Epub 2011 Dec 14.

3.

Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.

Li J, Zhang XS, Xie D, Deng HX, Gao YF, Chen QY, Huang WL, Masucci MG, Zeng YX.

Cancer Biol Ther. 2007 Dec;6(12):1997-2004. Epub 2007 Oct 13.

PMID:
18087217
4.

[Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].

Liu QY, Han AJ, You SY, Dong Y, Yang QX, Wu JH, Li MF.

Ai Zheng. 2008 Oct;27(10):1070-6. Chinese.

PMID:
18851787
5.

[Role of Wnt5a and LMP1 in the nasopharyngeal carcinogenesis by high-throughput tissue microarray technology].

Xu L, Zheng J, Li J, Shi L, Fan S.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Sep;37(9):865-70. Chinese.

6.

Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.

Lee DC, Chua DT, Wei WI, Sham JS, Lau AS.

Biomed Pharmacother. 2007 Oct;61(9):520-6. Epub 2007 Sep 14.

PMID:
17913445
7.

Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.

Rosales-Pérez S, Cano-Valdez AM, Flores-Balcázar CH, Guedea-Edo F, Lino-Silva LS, Lozano-Borbalas A, Navarro-Martín A, Poitevin-Chacón A.

Arch Med Res. 2014 Apr;45(3):229-36. doi: 10.1016/j.arcmed.2014.02.002. Epub 2014 Mar 4.

PMID:
24606815
8.

A novel LMP1 antibody synergizes with mitomycin C to inhibit nasopharyngeal carcinoma growth in vivo through inducing apoptosis and downregulating vascular endothelial growth factor.

Mao Y, Zhang DW, Wen J, Cao Q, Chen RJ, Zhu J, Feng ZQ.

Int J Mol Sci. 2012;13(2):2208-18. doi: 10.3390/ijms13022208. Epub 2012 Feb 17.

9.

Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.

Zhong BL, Zong YS, Lin SX, Zhang M, Liang YJ.

Ai Zheng. 2006 Feb;25(2):136-42.

PMID:
16480574
10.
11.

[Application of EB virus latent membrane protein 1 in nasopharyngeal swab in diagnosis of nasopharyngeal carcinoma].

Xie Y, Huang G, Zhang Z, Wen W, Wu Y, Wei Z.

Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2006 Jun;20(11):499-501. Chinese.

PMID:
16929830
13.
14.
15.

Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.

Xiao L, Hu ZY, Dong X, Tan Z, Li W, Tang M, Chen L, Yang L, Tao Y, Jiang Y, Li J, Yi B, Li B, Fan S, You S, Deng X, Hu F, Feng L, Bode AM, Dong Z, Sun LQ, Cao Y.

Oncogene. 2014 Sep 11;33(37):4568-78. doi: 10.1038/onc.2014.32. Epub 2014 Mar 24.

16.
17.

Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.

Shao JY, Ernberg I, Biberfeld P, Heiden T, Zeng YX, Hu LF.

Anticancer Res. 2004 Jul-Aug;24(4):2309-18.

18.

Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.

Murono S, Yoshizaki T, Park CS, Furukawa M.

Histopathology. 1999 May;34(5):432-8.

PMID:
10231418
19.

EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.

Khabir A, Karray H, Rodriguez S, Rosé M, Daoud J, Frikha M, Boudawara T, Middeldorp J, Jlidi R, Busson P.

Virol J. 2005 Apr 20;2:39.

20.

Presence of Epstein-Barr virus latent membrane protein 1 gene in the nasopharyngeal swabs from patients with nasopharyngeal carcinoma.

Lin SY, Tsang NM, Kao SC, Hsieh YL, Chen YP, Tsai CS, Kuo TT, Hao SP, Chen IH, Hong JH.

Head Neck. 2001 Mar;23(3):194-200.

PMID:
11428449

Supplemental Content

Support Center